Age (years) | 61 | ±14 | |
---|---|---|---|
Gender | male | 116 | 71 % |
female | 48 | 29 % | |
APACHE II | 21 | ±9 | |
SOFA (at time of BAL) | 7 | ±4 | |
Parameters (at time of BAL) | pH <7.25 | 10 | 6 % |
PaCO2 ≥ 7.5kPa (56 mmHg) | 9 | 5 % | |
PaO2 ≤ 8kPa (60 mmHg) | 10 | 6 % | |
PaO2/FiO2 ratio ≤ 13kPa (100 mmHg) | 12 | 7 % | |
Diagnosis upon admission | respiratory | 64 | 38 % |
cardiovascular | 37 | 22 % | |
haematological | 19 | 11 % | |
gastrointestinal | 16 | 10 % | |
trauma/orthopaedic | 10 | 6 % | |
neurological | 12 | 7 % | |
urogenital | 3 | 2 % | |
other | 7 | 4 % | |
Severe Sepsis at admission | 52 | 32 % | |
Co-morbidity | none | 53 | 33 % |
one item | 72 | 44 % | |
two items | 35 | 21 % | |
≥ three items | 4 | 2 % | |
Co-morbidity | cardiovascular | 34 | 21 % |
respiratory | 12 | 7 % | |
chronic renal failure | 8 | 5 % | |
immunocompromised | 47 | 29 % | |
active malignancy | 32 | 20 % | |
neurologic impairment | 17 | 10 % | |
coagulation disorder | 3 | 2 % | |
chronic hepatic failure | 2 | 1 % | |
BAL positive | 68 | 41 % | |
ICU mortality | 80 | 49 % | |
In-hospital mortality | 90 | 55 % | |
Cause of death | cardiovascular | 13 | 15 % |
persistent respiratory failure | 24 | 27 % | |
neurological impairment | 9 | 10 % | |
multi organ failure | 10 | 11 % | |
active malignancy | 28 | 31 % | |
other | 4 | 4 % | |
unknown | 2 | 2 % |